"10.1371_journal.pone.0060933","plos one","2013-04-17T00:00:00Z","Modesto J Remuiñán; Esther Pérez-Herrán; Joaquín Rullás; Carlos Alemparte; María Martínez-Hoyos; David J Dow; Johnson Afari; Nalini Mehta; Jorge Esquivias; Elena Jiménez; Fátima Ortega-Muro; María Teresa Fraile-Gabaldón; Vickey L Spivey; Nicholas J Loman; Mark J Pallen; Chrystala Constantinidou; Douglas J Minick; Mónica Cacho; María José Rebollo-López; Carolina González; Verónica Sousa; Iñigo Angulo-Barturen; Alfonso Mendoza-Losana; David Barros; Gurdyal S Besra; Lluís Ballell; Nicholas Cammack","Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain; Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom; School of Biosciences, University of Birmingham, Edgbaston, United Kingdom; Department of Analytical Chemistry, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America","Conceived and designed the experiments: MJR EPH JR CA DJD EJ FOM MTFG IAB AML DB GSB LB NC. Performed the experiments: EPH JR CA MMH JA NM JE DJM MC MJRL CG VS. Analyzed the data: EPH JR JA NM FOM VLS NJL MJP CC DJM. Contributed reagents/materials/analysis tools: MC JE. Wrote the paper: MJR GSB LB.","The authors declare the following co-authors Modesto J. Remuiñán, Esther Pérez-Herrán, Joaquín Rullás, Carlos Alemparte, Maria Martinez-Hoyos, David J. Dow, Johnson Afari, Nalini Mehta, Jorge Esquivias, Elena Jiménez, Fátima Ortega-Muro, María Teresa Fraile-Gabaldón, Vickey L. Spivey, Douglas J. Minick, Mónica Cacho, María Jose Rebollo-Lopez, Carolina Gonzalez, Verónica Sousa, Iñigo Angulo- Barturen, Alfonso Mendoza-Losana, David Barros, Lluís Ballell and Nicholas Cammack are employed by GlaxoSmithKline. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. They also declare there is the following public patent (WO2012143522, Tetrahydropyrazolo [1,5-A] pyrimidine as anti-tuberculosis compounds, 20 April 2012) relating to material pertinent to this article. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Modesto J Remuiñán","MJR",27,TRUE,14,12,10,3,TRUE,TRUE,FALSE,0,NA,FALSE
